Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3839) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank European Medicines Agency holds first meeting of Committee for Advanced Therapies (CAT) 16 Ιανουάριος 2009Press releaseHumanAdvanced therapiesMedicinesInnovation Priority access for children during Myozyme supply shortage 16 Ιανουάριος 2009Press releaseHumanPaediatrics Committee for medicinal products for veterinary use: Meeting of 13-15 January 2009 16 Ιανουάριος 2009Press releaseVeterinary Gendux Molecular Limited withdraws its marketing authorisation application for Advexin (contusugene ladenovec) 19 Δεκέμβριος 2008Press release Meeting highlights from the Committee for Medicinal Products for Human Use,15-18 December 2008 18 Δεκέμβριος 2008Press releaseHuman Meeting highlights from the Paediatric Committee: 10 - 12 December 2008 17 Δεκέμβριος 2008Press releaseHumanPaediatrics EMEA Management Board adopts work programme for a busy year ahead and agrees to move towards greater transparency of its meetings 17 Δεκέμβριος 2008Press releaseCorporate Janssen-Cilag International N.V. withdraws its application for an extension of indication for Invega (paliperidone) 17 Δεκέμβριος 2008Press releaseHuman European Medicines Agency recommends suspension of classical swine fever vaccine Porcilis Pesti 12 Δεκέμβριος 2008Press releaseVeterinaryMedicines Committee for medicinal products for veterinary use: Meeting of 9-11 December 2008 12 Δεκέμβριος 2008Press releaseVeterinary 1 … 307 308 309 310 311 Page 311 of 384 312 313 314 315 … 384
European Medicines Agency holds first meeting of Committee for Advanced Therapies (CAT) 16 Ιανουάριος 2009Press releaseHumanAdvanced therapiesMedicinesInnovation
Priority access for children during Myozyme supply shortage 16 Ιανουάριος 2009Press releaseHumanPaediatrics
Committee for medicinal products for veterinary use: Meeting of 13-15 January 2009 16 Ιανουάριος 2009Press releaseVeterinary
Gendux Molecular Limited withdraws its marketing authorisation application for Advexin (contusugene ladenovec) 19 Δεκέμβριος 2008Press release
Meeting highlights from the Committee for Medicinal Products for Human Use,15-18 December 2008 18 Δεκέμβριος 2008Press releaseHuman
Meeting highlights from the Paediatric Committee: 10 - 12 December 2008 17 Δεκέμβριος 2008Press releaseHumanPaediatrics
EMEA Management Board adopts work programme for a busy year ahead and agrees to move towards greater transparency of its meetings 17 Δεκέμβριος 2008Press releaseCorporate
Janssen-Cilag International N.V. withdraws its application for an extension of indication for Invega (paliperidone) 17 Δεκέμβριος 2008Press releaseHuman
European Medicines Agency recommends suspension of classical swine fever vaccine Porcilis Pesti 12 Δεκέμβριος 2008Press releaseVeterinaryMedicines
Committee for medicinal products for veterinary use: Meeting of 9-11 December 2008 12 Δεκέμβριος 2008Press releaseVeterinary